Skip to main content

Articles

Keytruda Now Approved for the Adjuvant Treatment of Stage IIB/IIC Melanoma

Orencia First Drug FDA Approved for the Prevention of Acute Graft-versus-Host Disease

Kimmtrak, a Bispecific CD3 T-Cell Engager, First FDA-Approved Drug for Unresectable or Metastatic Uveal Melanoma

FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor

Oral Scemblix FDA Approved for Patients with Ph-Positive Chronic Myeloid Leukemia

Tecartus FDA Approved for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Verzenio with Endocrine Therapy FDA Approved for Adjuvant Treatment of Early Breast Cancer

A Pandemic Literary Genre

David B. Nash, MD, MBA

Need for Expansion of Coverage for Narrowband UVB Phototherapy in Mycosis Fungoides and Sézary Syndrome

Agnes Kim, MS; Amelia Insley, BA; Lindsey West, MD; Heather Woodworth Goff, MD

Original Research, Practice Management

Granisetron Extended-Release Subcutaneous Injection versus Palonosetron Infusion for CINV Prevention: Cost Comparison of Unscheduled Hydration

Martin Barnes, MD; George Calcanes, BS, RN; Michael C. Mosier, PhD; Jeffrey Vacirca, MD, FACP; Zulfiqar Malik, MD, PhD

Page 17 of 244
Results 161 - 170 of 2434